HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cancer Letters

• Publication date

  2018-02-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2017.11.018PMID 29174803
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Upregulating the Expression of Survivin-HBXIP Complex Contributes to the Protective Role of IMM-H004 in Transient Global Cerebral Ischemia/Reperfusion

  2018cited by this paper
• MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer

  2018cited by this paper
• MicroRNAs‐Based Imaging Techniques in Cancer Diagnosis and Therapy

  2017cited by this paper
• Macrophage Polarization: Anti‐Cancer Strategies to Target Tumor‐Associated Macrophage in Breast Cancer

  2017cited by this paper
• MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3′-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein*

  2017cited by this paper
• m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells

  2017cited by this paper
• m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.

  2017cited by this paper
• The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer.

  2017cited by this paper
• The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells.

  2016cited by this paper
• Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade.

  2016cited by this paper
• HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc.

  2016cited by this paper
• BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.

  2016cited by this paper
• Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth

  2016cited by this paper
• m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation

  2015cited by this paper
• The let-7g microRNA promotes follicular granulosa cell apoptosis by targeting transforming growth factor-β type 1 receptor.

  2015cited by this paper
• m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency.

  2015cited by this paper
• Structures of Human ALKBH5 Demethylase Reveal a Unique Binding Mode for Specific Single-stranded N6-Methyladenosine RNA Demethylation*

  2014cited by this paper
• Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase

  2014cited by this paper
• Methyltransferases modulate RNA stability in embryonic stem cells

  2014cited by this paper
• The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF.

  2014cited by this paper
• The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells.

  2014cited by this paper
• Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites.

  2014cited by this paper
• The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells

  2013cited by this paper
• ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility.

  2013cited by this paper
• The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells

  2013cited by this paper
• m6A-dependent regulation of messenger RNA stability

  2013cited by this paper
• RNA-methylation-dependent RNA processing controls the speed of the circadian clock.

  2013cited by this paper
• A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation

  2013cited by this paper
• Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons.

  2012cited by this paper
• Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq

  2012cited by this paper
• Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1.

  2012cited by this paper
• N6-methyl-adenosine (m6A) in RNA: An Old Modification with A Novel Epigenetic Function

  2012cited by this paper
• Grand challenge commentary: RNA epigenetics?

  2010cited by this paper
• Lin28: A microRNA regulator with a macro role.

  2010cited by this paper
• Yeast targets for mRNA methylation

  2010cited by this paper
• A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment

  2008cited by this paper
• let-7 microRNAs in development, stem cells and cancer.

  2008cited by this paper
• The let-7 family of microRNAs.

  2008cited by this paper
• Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing.

  2008cited by this paper
• Selective Blockade of MicroRNA Processing by Lin28

  2008cited by this paper
• let-7 regulates self renewal and tumorigenicity of breast cancer cells.

  2007cited by this paper
• HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis.

  2006cited by this paper
• Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.

  2006cited by this paper
• RAS is regulated by the let-7 microRNA family.

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• Identification of Novel Genes Coding for Small Expressed RNAs

  2001cited by this paper
• An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans

  2001cited by this paper
• Cloning and Characterization of a Novel Hepatitis B Virus x Binding Protein That Inhibits Viral Replication

  1998cited by this paper
• Methylated nucleotides block 5' terminus of HeLa cell messenger RNA.

  1975cited by this paper

• m6A RNA modification and its emerging roles in diseases: recent advances and therapeutic implications.

  2026cites this paper
• Targeting epigenetic methylation: emerging diagnosis and therapeutic strategies in cancer

  2026cites this paper
• Recent Advances in Medicinal Chemistry Strategies for the Development of METTL3 Inhibitors

  2026cites this paper
• Recent advance in single-molecule counting for in vitro detection and in vivo imaging of RNA methylation and demethylation

  2026cites this paper
• METTL3-mediated m6A modification of FDX1 confers resistance to cuproptosis and promotes hepatocellular carcinoma progression

  2026cites this paper
• METTL3 safeguard cancer cells from programmed cell death during detachment from their surrounding extracellular matrix

  2026cites this paper
• Altered Expression of Mitochondrial Succinate Dehydrogenase Subunit D Influences Breast Cancer Progression.

  2026cites this paper
• Prognostic potential of N6-methyladenosine methylation-associated genes in lung adenocarcinoma

  2025cites this paper
• Advances in detection technologies for RNA m6A modifications and related enzymes: Strategies and applications

  2025cites this paper
• RNA Modifications in Health and Disease

  2025cites this paper
• The impact of METTL3 on bladder cancer through m6A modification: a potential therapeutic target and prognostic biomarker

  2025cites this paper
• m6A-lncRNA landscape highlights reduced levels of m6A modification in glioblastoma as compared to low-grade glioma

  2025cites this paper
• Functional and clinical significance of the RNA m6A methyltransferase complex in breast cancer

  2025cites this paper
• Epigenetic regulation of RNA methylations in gastric cancer

  2025cites this paper
• N6-methyladenosine RNA base modification regulates NKG2D-dependent and cytotoxic genes expression in natural killer cells

  2025cites this paper
• Rethinking RNA Modifications: Therapeutic Strategies for Targeting Dysregulated RNA.

  2025cites this paper
• circSCYL2 antagonizes hnRNPA2B1-mediated m6A-chromatin crosstalk to promote ferroptosis and inhibit metastasis of breast cancer to brain.

  2025cites this paper
• Epitranscriptomics Regulation of CD70, CD80, and TIGIT in Cancer Immunity

  2025cites this paper
• N6-methyladenosine-modified circ_0000517 promotes non-small cell lung cancer metastasis via miR-1233-3p/CDH6 axis

  2025cites this paper
• METTL3-mediated activation of Sonic Hedgehog signaling promotes breast cancer progression

  2025cites this paper
• Modifications of RNA in cancer: a comprehensive review

  2025cites this paper
• RNA epigenetic modifications as dynamic biomarkers in cancer: from mechanisms to clinical translation

  2025cites this paper
• Esketamine alleviates depressive-like behavior in neuropathic pain mice through the METTL3-GluA1 pathway

  2025cites this paper
• FTO promotes the progression of triple-negative breast cancer by regulating the m6A methylation of NFKBIE

  2025cites this paper
• METTL3 regulates Ambra1 expression in an m6A-YTHDF2-dependent manner to promote mantle cell lymphoma progression

  2025cites this paper
• Key epigenetic enzymes modulated by natural compounds contributes to tumorigenicity.

  2025cites this paper
• METTL3-mediated m6A modification of LINC00857 enhances stemness and metastasis of ovarian cancer cells by activating the YAP-TEAD pathway

  2025cites this paper
• Advances in RNA-based cancer therapeutics: pre-clinical and clinical implications

  2025cites this paper
• The functional and therapeutic potential of epitranscriptomics in breast cancer

  2025cites this paper
• Analysis of the mRNA modification machinery alterations in breast cancer through the SCAN-B cohort

  2025cites this paper
• Hypoxia-induced NSUN2 promotes the progression of colon cancer by modulating the discrepant cleavage of tRNA-Arg.

  2025cites this paper
• Research progress on oncoprotein hepatitis B X‑interacting protein (Review)

  2024cites this paper
• Liquid–liquid phase separation in diseases

  2024cites this paper
• Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy

  2024cites this paper
• The crosstalk between N6‐methyladenosine readers and neuroblastoma

  2024cites this paper
• The role of the ALKBH5 RNA demethylase in invasive breast cancer

  2024cites this paper
• The regulatory mechanism of m6A modification in gastric cancer

  2024cites this paper
• Arginine methylation of ALKBH5 by PRMT6 promotes breast tumorigenesis via LDHA-mediated glycolysis

  2024cites this paper
• Exploring methyl-verse: dynamic interplay of epigenome and m6A epitranscriptome.

  2024cites this paper
• Impact of METTL3/14/16 Gene Polymorphisms on Risk of Breast Cancer in Chinese Women.

  2024cites this paper
• MiR-186-5p prevents hepatocellular carcinoma progression by targeting methyltransferase-like 3 that regulates m6A-mediated stabilization of follistatin-like 5

  2024cites this paper
• MicroRNA Biogenesis Modulates mRNA N6-methyladenosine Methylation in Arabidopsis

  2024cites this paper
• Trends and frontiers of RNA methylation in cancer over the past 10 years: a bibliometric and visual analysis

  2024cites this paper
• Expression and role of methyltransferase 3 in oral malignant transformation.

  2024cites this paper
• Noncoding RNAs in rheumatoid arthritis: modulators of the NF-κB signaling pathway and therapeutic implications

  2024cites this paper
• Epigenetic contribution to cancer.

  2024cites this paper
• Refining the role of N6-methyladenosine in cancer.

  2024cites this paper
• Hypoxic stabilization of RIPOR3 mRNA via METTL3-mediated m6A methylation drives breast cancer progression and metastasis

  2024cites this paper
• Identifying subtypes and developing prognostic models based on N6-methyladenosine and immune microenvironment related genes in breast cancer

  2024cites this paper
• Functions of methyltransferase-like 3 in breast cancer: pathogenesis, drug resistance, and therapeutic target

  2024cites this paper
• Crosstalk between RNA m6A modification and epigenetic factors in plant gene regulation

  2024cites this paper
• Epitranscriptomic mechanisms of androgen signalling and prostate cancer

  2024cites this paper
• Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes.

  2024cites this paper
• Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles

  2024cites this paper
• Ramifications of m6A Modification on ncRNAs in Cancer

  2024cites this paper
• HBXIP induces PARP1 via WTAP-mediated m6A modification and CEBPA-activated transcription in cisplatin resistance to hepatoma

  2024cites this paper
• Virtual Screening and Molecular Docking: Discovering Novel METTL3 Inhibitors.

  2024cites this paper
• Functions and mechanisms of RNA m6A regulators in breast cancer (Review)

  2024cites this paper
• Internal m6A and m7G RNA modifications in hematopoietic system and acute myeloid leukemia

  2024cites this paper
• Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.

  2024cites this paper
• Small molecule inhibitors targeting m6A regulators

  2024cites this paper
• ELABELA-APJ Axis Enhances Mesenchymal Stem Cell Proliferation and Migration via the METTL3/PI3K/AKT Pathway

  2024cites this paper
• Unraveling the cross‐talk between N6‐methyladenosine modification and non‐coding RNAs in breast cancer: Mechanisms and clinical implications

  2024cites this paper
• Oncoprotein LAMTOR5-mediated CHOP silence via DNA hypermethylation and miR-182/miR-769 in promotion of liver cancer growth

  2024cites this paper
• Regulatory effects of natural products on N6-methyladenosine modification: A novel therapeutic strategy for cancer.

  2024cites this paper
• Bridging tissue repair and epithelial carcinogenesis: epigenetic memory and field cancerization

  2024cites this paper
• Recent advance in optical single-molecule detection of methylation modification and methyl-modifying enzymes

  2024cites this paper
• The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target

  2024cites this paper
• Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells

  2024cites this paper
• Emerging insights into keratin 7 roles in tumor progression and metastasis of cancers

  2024cites this paper
• METTL3‐mediated m6A modification of EPPK1 to promote the development of esophageal cancer through regulating the PI3K/AKT pathway

  2024cites this paper
• Proteolysis Targeting Chimera Degraders of the METTL3–14 m6A-RNA Methyltransferase

  2024cites this paper
• Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues

  2023cites this paper
• Analyses of m6A regulatory genes and subtype classification in atrial fibrillation

  2023cites this paper
• Elucidating the clinical and immunological value of m6A regulator-mediated methylation modification patterns in adrenocortical carcinoma

  2023cites this paper
• NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc

  2023cites this paper
• The roles and implications of RNA m6A modification in cancer

  2023cites this paper
• New insights on the interplays between m6A modifications and microRNA or lncRNA in gastrointestinal cancers

  2023cites this paper
• A cleaved METTL3 potentiates the METTL3-WTAP interaction and breast 1 cancer progression 2

  2023cites this paper
• The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma

  2023cites this paper
• Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment

  2023cites this paper
• Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment

  2023cites this paper
• Multi-dimensional structural footprint identification for the design of potential scaffolds targeting METTL3 in cancer treatment from natural compounds

  2023cites this paper
• Novel RNA m6A methyltransferase METTL16 inhibitors

  2023cites this paper
• m6A modification: a new avenue for anti-cancer therapy

  2023cites this paper
• METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.

  2023cites this paper
• Development of a N6-methyladenosine-directed single quantum dot-based biosensor for sensitive detection of METTL3/14 complex activity in breast cancer tissues.

  2023cites this paper
• Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors

  2023cites this paper
• Controllable assembly of dendritic DNA nanostructures for ultrasensitive detection of METTL3-METTL14 m6A methyltransferase activity in cancer cells and human breast tissues.

  2023cites this paper
• The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms

  2023cites this paper
• Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients

  2023cites this paper
• ALKBH5‐induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2

  2023cites this paper
• ACAT1-mediated METTL3 acetylation inhibits cell migration and invasion in triple negative breast cancer

  2023cites this paper
• Bioinformatics analysis of rheumatoid arthritis tissues identifies genes and potential drugs that are expressed specifically

  2023cites this paper
• A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression

  2023cites this paper
• METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2—breast cancer

  2023cites this paper
• RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines

  2023cites this paper
• RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4

  2023cites this paper
• METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey

  2023cites this paper
• Rheumatoid arthritis and non-coding RNAs; how to trigger inflammation.

  2023cites this paper